Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Cai W et al. | 2024 | intact cell/cell culture | magnetic field, 50/60 Hz | - |
| Lu ZJ et al. | 2024 | intact cell/cell culture, bone marrow-derived mesenchymal stem cells (BM-MSCs) | magnetic field, signals/pulses, 50/60 Hz | - |
| Isaković J et al. | 2024 | intact cell/cell culture, neural stem cells derived from B6 albino mouse embryos | magnetic field, 50/60 Hz, signals/pulses | - |
| Rahimi S et al. | 2023 | intact cell/cell culture, dental pulp multipotent stromal stem cells | magnetic field, signals/pulses, 50/60 Hz | - |
| Takahashi M et al. | 2023 | intact cell/cell culture, human hematopoietic stem/progenitor cells (CD34+ cells derived from human cord blood) | 50/60 Hz, magnetic field | - |
| Amirahmadi F et al. | 2023 | intact cell/cell culture, rat bone marrow-derived stem cells | magnetic field, 50/60 Hz, low frequency, also other exposures without EMF, co-exposure | - |
| Caliogna L et al. | 2022 | intact cell/cell culture, human adipose-derived mesenchymal stem cells and primary human osteoblasts | magnetic field, signals/pulses, 50/60 Hz, therapeutic/medical device | - |
| Huang L et al. | 2022 | intact cell/cell culture, mouse bone marrow-derived mesenchymal stem cells, animal, C57BL/6 mouse | magnetic field, signals/pulses, 50/60 Hz | - |
| Costantini E et al. | 2022 | - | magnetic field, low frequency, 50/60 Hz | - |
| Haroutunian GG et al. | 2022 | intact cell/cell culture, human adipose tissue‐derived mesenchymal stem progenitor cells (MSPCs) | magnetic field, intermediate frequency, 50/60 Hz | - |
| Takahashi M et al. | 2022 | intact cell/cell culture, human induced pluripotent stem cells | magnetic field, 50/60 Hz | - |
| Bi J et al. | 2022 | intact cell/cell culture, C2C12 cells (undifferentiated mouse myoblasts) | magnetic field, 50/60 Hz | 1.5–2 mT |
| Moraveji M et al. | 2021 | intact cell/cell culture, rat adipose-derived mesenchymal stem cells | magnetic field, 50/60 Hz, signals/pulses, also other exposures without EMF, co-exposure | - |
| Lim HM et al. | 2021 | intact cell/cell culture, human dental pulp stem cells | magnetic field, signals/pulses, low frequency, 50/60 Hz | 10 mT |
| Dong Y et al. | 2021 | intact cell/cell culture | magnetic field, signals/pulses, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| Bai W et al. | 2021 | intact cell/cell culture, neural stem cells from rat | 50/60 Hz, magnetic field | 5 mT–2.5 T |
| Zhou J et al. | 2021 | intact cell/cell culture, newborn rat calvarial osteoblasts, animal, rat/Wistar | magnetic field, 50/60 Hz, low frequency | 1.8 mT |
| Tabatabai TS et al. | 2021 | intact cell/cell culture, human adipose tissue-derived mesenchymal stem cells | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | 1 mT |
| Asadian N et al. | 2021 | intact cell/cell culture, rat bone marrow-derived mesenchymal stem cells | 50/60 Hz, magnetic field | 400 µT |
| Consales C et al. | 2021 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 1 mT |
| Li X et al. | 2020 | mouse/BALB/c (nude mice) | magnetic field, low frequency, 50/60 Hz | - |
| Hesari R et al. | 2020 | intact cell/cell culture, human adipose derived stem cells | magnetic field, 50/60 Hz, signals/pulses, co-exposure, also other exposures without EMF | 30 mT |
| Shapourzadeh A et al. | 2020 | intact cell/cell culture, adipose-derived stem cells | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | 31.4–62.8 µT |
| Jang YW et al. | 2019 | - | magnetic field, 50/60 Hz | - |
| Özgün A et al. | 2019 | intact cell/cell culture, human neural progenitor cells | magnetic field, 50/60 Hz | 1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
